During the past decade, Capio Citykliniken conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Capio Citykliniken" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "Karolinska University" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Capio Citykliniken" are "Atherosclerotic Cardiovascular Disease" (1 trials), "Cardiovascular Diseases" (1 trials), "Dyslipidemia" (1 trials), "Dyslipidemic" (1 trials) and "Erythema" (1 trials). Many other conditions were trialed in "Capio Citykliniken" in a lesser frequency.

Most popular intervention types in "Capio Citykliniken" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Brimonidine tartrate vehicle was applied cutaneously once daily for 8 days." (1 trials), "Brimonidine tartrate was applied cutaneously once daily for 8 days." (1 trials), "Evolocumab" (1 trials), "Non-interventional" (1 trials) and "Spironolactone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Capio Citykliniken" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Capio Citykliniken". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Capio Citykliniken, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Capio Citykliniken, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".